JP2011016729A - Aqueous external preparation for scalp - Google Patents
Aqueous external preparation for scalp Download PDFInfo
- Publication number
- JP2011016729A JP2011016729A JP2009160454A JP2009160454A JP2011016729A JP 2011016729 A JP2011016729 A JP 2011016729A JP 2009160454 A JP2009160454 A JP 2009160454A JP 2009160454 A JP2009160454 A JP 2009160454A JP 2011016729 A JP2011016729 A JP 2011016729A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- extract
- scalp
- external preparation
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004761 scalp Anatomy 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 54
- 229920001577 copolymer Polymers 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 8
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940046009 vitamin E Drugs 0.000 claims abstract description 5
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 5
- 239000011709 vitamin E Substances 0.000 claims abstract description 5
- -1 N, N-dimethylaminoethyl Chemical group 0.000 claims description 28
- 230000017531 blood circulation Effects 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 229940007062 eucalyptus extract Drugs 0.000 claims description 9
- 229920001296 polysiloxane Polymers 0.000 claims description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 8
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 7
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 claims description 7
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 7
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- RWHRFHQRVDUPIK-UHFFFAOYSA-N 50867-57-7 Chemical compound CC(=C)C(O)=O.CC(=C)C(O)=O RWHRFHQRVDUPIK-UHFFFAOYSA-N 0.000 claims description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 229920002873 Polyethylenimine Polymers 0.000 claims description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 2
- 229960003720 enoxolone Drugs 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 claims description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 210000004209 hair Anatomy 0.000 abstract description 29
- 244000166124 Eucalyptus globulus Species 0.000 abstract description 5
- 150000002814 niacins Chemical class 0.000 abstract description 4
- 241000967294 Swertia japonica Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000000605 extraction Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 241000269333 Caudata Species 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 3
- 150000002216 flavonol derivatives Chemical class 0.000 description 3
- 235000011957 flavonols Nutrition 0.000 description 3
- 230000003648 hair appearance Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- PMUWWDBIGFMHAW-SJORKVTESA-N (2r,3r)-3-hydroxy-3-methyl-2-(4-methylphenyl)-2h-chromen-4-one Chemical compound C1=CC(C)=CC=C1[C@@H]1[C@](O)(C)C(=O)C2=CC=CC=C2O1 PMUWWDBIGFMHAW-SJORKVTESA-N 0.000 description 2
- NYEZZYQZRQDLEH-UHFFFAOYSA-N 2-ethyl-4,5-dihydro-1,3-oxazole Chemical compound CCC1=NCCO1 NYEZZYQZRQDLEH-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 2
- 241000546188 Hypericum Species 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 244000014047 Polianthes tuberosa Species 0.000 description 2
- 235000016067 Polianthes tuberosa Nutrition 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 2
- ZTLBKEBOAKWETD-UHFFFAOYSA-N [Na].[N+](=O)([O-])C1=C(C(=CC=C1)OC)O Chemical compound [Na].[N+](=O)([O-])C1=C(C(=CC=C1)OC)O ZTLBKEBOAKWETD-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229960003001 adenosine triphosphate disodium Drugs 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940069780 barley extract Drugs 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 2
- 229940008406 diethyl sulfate Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- VMKSKORGKQPVAO-VIFPVBQESA-N ethyl 3-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound CCOC(=O)CCNC(=O)[C@H](O)C(C)(C)CO VMKSKORGKQPVAO-VIFPVBQESA-N 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940038487 grape extract Drugs 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229950001046 piroctone Drugs 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000004036 potassium channel stimulating agent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- IVVNZDGDKPTYHK-JTQLQIEISA-N 1-cyano-2-[(2s)-3,3-dimethylbutan-2-yl]-3-pyridin-4-ylguanidine Chemical compound CC(C)(C)[C@H](C)N=C(NC#N)NC1=CC=NC=C1 IVVNZDGDKPTYHK-JTQLQIEISA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- BFZHCUBIASXHPK-QJSKAATBSA-N 11alpha-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)C[C@H]2O BFZHCUBIASXHPK-QJSKAATBSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol Chemical compound C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- RESQVPCTJIALIE-UHFFFAOYSA-N 2-methylprop-2-enoic acid;sulfuric acid Chemical compound OS(O)(=O)=O.CC(=C)C(O)=O RESQVPCTJIALIE-UHFFFAOYSA-N 0.000 description 1
- NDAJNMAAXXIADY-UHFFFAOYSA-N 2-methylpropanimidamide Chemical compound CC(C)C(N)=N NDAJNMAAXXIADY-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- VISDUEJJQYPGIZ-UHFFFAOYSA-N Delamide Natural products COC(=O)C1=CC=CC=C1NC(=O)C(C)CC(N)=O VISDUEJJQYPGIZ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 241000272185 Falco Species 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 241001296405 Tiso Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940029991 coriander extract Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229960004042 diazoxide Drugs 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical compound [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 229960002074 flutamide Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960002310 pinacidil Drugs 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940068988 potassium aspartate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940092385 radish extract Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- SLYPOVJCSQHITR-UHFFFAOYSA-N tioxolone Chemical compound OC1=CC=C2SC(=O)OC2=C1 SLYPOVJCSQHITR-UHFFFAOYSA-N 0.000 description 1
- 229960003070 tioxolone Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、水性頭皮外用剤に関する。 The present invention relates to an aqueous scalp external preparation.
従来より、養毛・育毛料に期待される機能として、薄毛の改善、抜け毛の減少、髪のハリコシ感の向上といった髪質改善効果が挙げられる。しかしながら、特許文献1に記載される養育毛剤等は、髪のハリコシ感の向上は得られるものの、髪のごわつきが残り、髪質改善効果には不十分である。また、特許文献2のように、ごわつきを改善した技術も公開されているが、べたつきは改善されていない。現在より優れた髪質の即効改善効果が望まれ、ポリマーの種類を変えた水性頭皮外用剤(特許文献3参照)等も報告されている。 Conventionally, functions expected for hair nourishing and hair-growth include hair quality improvement effects such as thinning hair, reduction of hair loss, and improvement in hair tension. However, although the hair nurturing agent described in Patent Document 1 can improve the harshness of the hair, the hair remains stiff and is insufficient for the hair quality improvement effect. Further, as in Patent Document 2, a technique for improving the stiffness is disclosed, but the stickiness is not improved. The effect of improving the immediate effect of hair quality superior to the present is desired, and an aqueous scalp external preparation (see Patent Document 3) in which the type of polymer is changed has been reported.
従来の水性頭皮外用剤は、使用直後の髪において、べたつきが多く、ボリューム感がなく、満足のいく仕上がりではなかった。
そこで、本発明は、特定のポリマーを組み合わせることで、べたつかずに毛髪のボリューム感を改善する水性頭皮外用剤を提供するものである。
Conventional aqueous scalp external preparations have a lot of stickiness in hair immediately after use, have no voluminous feel, and are not satisfactory.
Then, this invention provides the aqueous | water-based scalp external preparation which improves the volume feeling of hair without stickiness by combining a specific polymer.
本発明は、(A)センブリエキス、ビタミンE類、ニコチン酸類から選ばれる少なくとも1種の血行促進成分および(B)ユーカリエキスに、特定の(C)N−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体および(D)N,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体を組み合せ、さらに(E)エタノール及び(F)水を含有する水性頭皮外用剤を提供するものである。 The present invention relates to a specific (C) N-propionylpolyethyleneimine / methylpolysiloxane co-polymerized with (A) at least one blood circulation promoting component selected from assembly extract, vitamin E, nicotinic acid and (B) eucalyptus extract. An aqueous solution containing a combination of (D) N, N-dimethylaminoethyl diethyl methacrylate methacrylate / N, N-dimethylacrylamide / polyethylene glycol dimethacrylate copolymer and further containing (E) ethanol and (F) water An external preparation for scalp is provided.
本発明によれば、べたつかずに毛髪のボリューム感を改善する水性頭皮外用剤を提供する。 ADVANTAGE OF THE INVENTION According to this invention, the aqueous scalp external preparation which improves the volume feeling of hair without stickiness is provided.
以下、本発明の実施形態を説明する。
本実施形態の水性頭皮外用剤は、
次の成分(A)〜(F):
(A)センブリエキス、ビタミンE類、およびニコチン酸類から選ばれる少なくとも1種の血行促進成分;
(B)ユーカリエキス;
(C)1×10−1〜1×10質量%のN−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体;
(D)5×10−2〜5質量%のN,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体;
(E)2×10〜6×10質量%のエタノール;
及び(F)水を含有する水性頭皮外用剤であることが好ましい。次に各成分について詳細に説明する。
Embodiments of the present invention will be described below.
The aqueous scalp external preparation of this embodiment is
The following components (A) to (F):
(A) at least one blood circulation promoting component selected from assembly extract, vitamin E, and nicotinic acid;
(B) Eucalyptus extract;
(C) 1 × 10 −1 to 1 × 10 mass% of N-propionylpolyethyleneimine / methylpolysiloxane copolymer;
(D) 5 × 10 −2 to 5% by mass of N, N-dimethylaminoethyl diethyl methacrylate methacrylate / N, N-dimethylacrylamide / polyethylene glycol dimethacrylate copolymer;
(E) 2 × 10-6 × 10 mass% ethanol;
And (F) an aqueous scalp external preparation containing water is preferable. Next, each component will be described in detail.
(成分(A))
成分(A)は、センブリエキス、ビタミンE類、ニコチン酸類から選ばれる少なくとも1種の血行促進成分である。具体的には、センブリエキス、ビタミンE類(DL−α−トコフェロール、D−α−トコフェロール、酢酸DL−α−トコフェロール、酢酸D−α−トコフェロール等)、ニコチン酸類(ニコチン酸、DL−α−トコフェロールニコチン酸エステル、ニコチン酸アミド、ニコチン酸ベンジル等)を挙げることができる。なかでも、頭皮の血行を促進するうえで、酢酸DL−α−トコフェロール、ニコチン酸アミド、センブリエキスが好ましく、これらは1種または2種以上を組み合せて用いることができる。特に、頭皮の血行を促進し、毛髪のハリコシに寄与する観点で、ニコチン酸アミド、センブリエキスが好ましい。
(Ingredient (A))
Component (A) is at least one blood circulation promoting component selected from assembly extract, vitamin Es, and nicotinic acids. Specifically, assembly extract, vitamin E (DL-α-tocopherol, D-α-tocopherol, DL-α-tocopherol acetate, D-α-tocopherol acetate, etc.), nicotinic acids (nicotinic acid, DL-α- Tocopherol nicotinate, nicotinamide, benzyl nicotinate, etc.). Of these, DL-α-tocopherol acetate, nicotinic acid amide and assembly extract are preferable for promoting blood circulation of the scalp, and these can be used alone or in combination of two or more. In particular, nicotinamide and assembly extract are preferable from the viewpoint of promoting blood circulation of the scalp and contributing to hair elasticity.
成分(A)の血行促進剤である、センブリエキスは、全組成中に、乾燥質量として1×10−5〜1質量%、好ましくは1×10−4〜1×10−1質量%、さらに頭皮の血行を促進する観点で、1×10−3〜5×10−2質量%含有されることが好ましい。ビタミンE類、ニコチン酸類は、1×10−4〜3質量%、好ましくは1×10−3〜1質量%、さらに頭皮の血行を促進する観点で、1×10−2〜5×10−1質量%含有されることが好ましい。 The assembly extract, which is a blood circulation promoter of component (A), has a dry mass of 1 × 10 −5 to 1% by mass, preferably 1 × 10 −4 to 1 × 10 −1 % by mass, From the viewpoint of promoting blood circulation of the scalp, it is preferable to contain 1 × 10 −3 to 5 × 10 −2 mass%. Vitamin Es and nicotinic acids are 1 × 10 −4 to 3% by mass, preferably 1 × 10 −3 to 1% by mass, and 1 × 10 −2 to 5 × 10 − in terms of promoting blood circulation of the scalp. It is preferable to contain 1 mass%.
(成分(B))
成分(B)のユーカリエキスは、フトモモ科ユーカリ属植物であるユーカリプタス・グロブラス〔学名:Eucalyptus globulus、ユーカリノキ〕の葉、枝等をそのまま、又は乾燥粉砕して、溶剤抽出し、濃縮することにより得られたエキスであり、保湿剤や抗菌、殺菌、血行促進、収斂効果などを有するものとして一般には使用されているものである。また、市販品を利用することもできる。なお、抽出溶剤としては、通常、植物成分の抽出に用いられる溶剤、例えば、水、石油エーテル、n−ヘキサン、トルエン、ジクロロエタン、クロロホルム、エーテル、酢酸エチル、アセトン、メタノール、エタノール、プロパノール、ブタノール、エチレングリコール、プロピレングリコール、ブチレングリコール等を用いることができる、特に水、エタノール、プロピレングリコール、ブチレングリコールを好ましく使用できる。これらは2種以上を組み合わせて使用してもよい。また、抽出条件も従来のユーカリエキスの抽出条件を踏襲することができ、例えば上記植物を抽出溶剤に3〜100℃で数時間〜数週間浸漬したり、抽出溶剤を加熱還流させたりすることが挙げられる。
(Ingredient (B))
The eucalyptus extract of component (B) is obtained by extracting the leaves, branches, etc. of Eucalyptus globulus [scientific name: Eucalyptus globulus], which is a eucalyptus family Eucalyptus plant, as they are or by dry pulverization, solvent extraction and concentration. The extract is generally used as a moisturizer, antibacterial, antibacterial, blood circulation promotion, astringent effect and the like. Moreover, a commercial item can also be utilized. In addition, as an extraction solvent, a solvent usually used for extraction of plant components, for example, water, petroleum ether, n-hexane, toluene, dichloroethane, chloroform, ether, ethyl acetate, acetone, methanol, ethanol, propanol, butanol, Ethylene glycol, propylene glycol, butylene glycol and the like can be used, and water, ethanol, propylene glycol and butylene glycol can be preferably used. You may use these in combination of 2 or more type. Moreover, the extraction conditions can follow the extraction conditions of the conventional eucalyptus extract. For example, the above plant can be immersed in the extraction solvent at 3 to 100 ° C. for several hours to several weeks, or the extraction solvent can be heated to reflux. Can be mentioned.
成分(B)のユーカリエキスは、全組成中に、乾燥質量として1×10−5〜1質量%、好ましくは1×10−4〜1×10−1質量%、より好ましくは1×10−3〜5×10−2質量%である。この範囲での配合により、頭皮や毛髪のべたつきを抑制し、毛髪の感触を損なわないようにできる。 Eucalyptus extract component (B), based on the whole composition, 1 × 10 -5 to 1 wt% as dry weight, preferably 1 × 10 -4 ~1 × 10 -1 wt%, more preferably 1 × 10 - 3 to 5 × 10 −2 mass%. By blending in this range, stickiness of the scalp and hair can be suppressed and the feel of hair can be prevented from being impaired.
(成分(C))
成分(C)のN−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体は、下記一般式(1)で表される。
(Ingredient (C))
The component (C) N-propionyl polyethyleneimine / methyl polysiloxane copolymer is represented by the following general formula (1).
(式中、R2はC2H5を示し、mは20〜10000の数を示し、nは20〜10000の数を示し、xおよびyはそれぞれ5〜100の数を示し、及びY−は陰イオンを示す。)で表されるものが好ましい。
上記一般式(1)中の陰イオンY−は、エチルスルフェート陰イオン等が挙げられる。)
(Wherein R 2 represents C 2 H 5 , m represents a number of 20 to 10000, n represents a number of 20 to 10000, x and y each represents a number of 5 to 100, and Y − Represents an anion).
Examples of the anion Y − in the general formula (1) include an ethyl sulfate anion. )
成分(C)の重量平均分子量(MWt)は、毛髪がべたつかない感触になることから、35000〜130000、なかでも85000〜120000が好ましい。 The weight average molecular weight (MWt) of the component (C) is preferably 35,000 to 130,000, and more preferably 85,000 to 120,000, because the hair does not feel sticky.
成分(C)のポリ(N−プロピオニルポリエチレンイミン)セグメントの分子量(MWox)は、GPC測定法により測定される数平均分子量をいい、好ましくは700〜3000、より好ましくは1000〜2800である。これにより、毛髪を滑らかにし、ふんわりした仕上がりにすることができる。 The molecular weight (MWox) of the poly (N-propionylpolyethyleneimine) segment of component (C) refers to the number average molecular weight measured by GPC measurement method, preferably 700 to 3000, more preferably 1000 to 2800. As a result, the hair can be made smooth and have a soft finish.
主鎖を構成するオルガノポリシロキサンセグメントの重量平均分子量(MWsi)は30000〜110,000であるが、毛髪を滑らかにし、ふんわりした仕上がりにする観点から、好ましくは80,000〜100,000が好ましい。 The weight average molecular weight (MWsi) of the organopolysiloxane segment constituting the main chain is 30,000 to 110,000, but preferably 80,000 to 100,000 from the viewpoint of making the hair smooth and soft. .
重量平均分子量は、GPCにより下記条件で測定されたポリスチレン換算の重量平均分子量である。
カラム:Super HZ4000+Super HZ2000(東ソー株式会社製)
溶離液:1mMトリエチルアミン/THF
流量 :0.35mL/min
カラム温度:40℃
検出器:UV
サンプル:50μL
The weight average molecular weight is a polystyrene equivalent weight average molecular weight measured by GPC under the following conditions.
Column: Super HZ4000 + Super HZ2000 (manufactured by Tosoh Corporation)
Eluent: 1 mM triethylamine / THF
Flow rate: 0.35 mL / min
Column temperature: 40 ° C
Detector: UV
Sample: 50 μL
成分(C)重量平均分子量(MWt)中の主鎖であるメチルポリシロキサンセグメントの重量平均分子量(MWsi)の質量含有率が50〜98%のものが、毛髪がふんわりした感触で、ボリューム感が得られる。なかでも80〜95%が好ましい。 The mass content of the weight average molecular weight (MWsi) of the methylpolysiloxane segment, which is the main chain in the component (C) weight average molecular weight (MWt), is 50 to 98%. can get. Of these, 80 to 95% is preferable.
成分(C)は、全組成中に、1×10−1〜1×10質量%含有できる。好ましくは1×10−1〜5質量%、特に好ましくは5×10−1〜3質量%である。また、この範囲での配合により、頭皮や毛髪のべたつきを抑制し、毛髪の感触を損なわないようにできる。 The component (C) can be contained in the total composition at 1 × 10 −1 to 1 × 10 mass%. Preferably it is 1 * 10 < -1 > -5 mass%, Most preferably, it is 5 * 10 < -1 > -3 mass%. Further, by blending in this range, it is possible to suppress the stickiness of the scalp and hair so as not to impair the feel of the hair.
(成分(D))
成分(D)のN,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体は、分子量500〜3000の範囲のものが好ましく、なかでも、さらに1000〜2000の範囲、特に1200〜1800の範囲のものが好ましい。
(Component (D))
The component (D) N, N-dimethylaminoethyl diethyl methacrylate methacrylate / N, N-dimethylacrylamide / polyethylene glycol dimethacrylate copolymer preferably has a molecular weight in the range of 500 to 3000. The range of 1000-2000, especially the range of 1200-1800 is preferable.
成分(D)のN,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体の含有量は、水性頭皮外用剤全量中に好ましくは5×10−2〜5重量%、好ましくは1×10−1〜5質量%、特に好ましくは3×10−1〜3質量%である。また、この範囲での含有により、頭皮や毛髪のべたつきを抑制し、毛髪の感触に優れている。
水性頭皮外用剤中の成分(C)のN−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体と、成分(D)のN,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体の含有比は、質量比で(C)/(D)=1/2〜10/1であることが好ましい。なかでも質量比で(C)/(D)=1/1〜5/1にすることで、成分(A)、成分(B)で血行促進された頭皮から生える毛髪の根元にこれらの成分が吸着し、クッションの役目をするため、毛髪を根元から立ち上げる効果が得られ、その結果、しなやかで、ボリューム感のある毛髪にすることができる。
The content of the component (D) N, N-dimethylaminoethyl diethyl methacrylate methacrylate / N, N-dimethylacrylamide / polyethylene glycol dimethacrylate copolymer is preferably 5 × 10 in the total amount of the aqueous scalp external preparation. −2 to 5% by weight, preferably 1 × 10 −1 to 5% by weight, particularly preferably 3 × 10 −1 to 3% by weight. Moreover, by containing in this range, the stickiness of a scalp and hair is suppressed and it is excellent in the touch of hair.
Component (C) N-propionylpolyethyleneimine / methylpolysiloxane copolymer in aqueous scalp external preparation, component (D) N, N-dimethylaminoethyl diethyl methacrylate sulfate, N, N-dimethylacrylamide, The content ratio of the polyethylene glycol dimethacrylate copolymer is preferably (C) / (D) = 1/2 to 10/1 by mass ratio. Above all, by setting the mass ratio to (C) / (D) = 1/1 to 5/1, these components can be found at the base of the hair that grows from the scalp whose blood circulation is promoted by the components (A) and (B). Since it absorbs and acts as a cushion, the effect of raising the hair from the root is obtained, and as a result, it is possible to make the hair supple and voluminous.
(成分(E))
成分(E)のエタノールの含有量は、全組成中に2×10〜6×10質量%である。
より好ましくは3×10〜5.5×10質量%である。
(Ingredient (E))
Content of ethanol of a component (E) is 2 * 10-6 * 10 mass% in the whole composition.
More preferably, it is 3 * 10-5.5 * 10 mass%.
(成分(F))
成分(F)の水の含有量は、全組成中に、好ましくは、3×10〜7.5×10質量%、より好ましくは、4×10〜7.3×10質量%である。
(Ingredient (F))
The water content of the component (F) is preferably 3 × 10 to 7.5 × 10 mass%, more preferably 4 × 10 to 7.3 × 10 mass% in the entire composition.
本発明の水性頭皮外用剤には、さらに、成分(G)フラバノノール類を含有することができる。フラバノノール類としては、特開平8−157464号公報又は特開平8−157334号公報記載の合成フラバノノール類のいずれも使用することができる。これらのうち、特にトランス−3,4'−ジメチル−3−ヒドロキシフラバノンが好ましい。フラバノノール類は少なくとも1種または2種以上含有することができる。全組成中の含有量は、育毛効果及び健康な頭皮への改善効果の面から1×10−3〜2質量%が好ましく、なかでも5×10−3〜1質量%、特に1×10−2〜8×10−1質量%が好ましい。 The aqueous scalp external preparation of the present invention can further contain a component (G) flavonols. As the flavonols, any of the synthetic flavonols described in JP-A-8-157464 or JP-A-8-157334 can be used. Of these, trans-3,4′-dimethyl-3-hydroxyflavanone is particularly preferable. Flavanols can be contained in at least one or two or more. Content in the whole composition is preferably from 1 × 10 -3 to 2 wt% from the viewpoint of improvement of the hair growth effects and healthy scalp, inter alia 5 × 10 -3 to 1 wt%, especially 1 × 10 - 2 to 8 × 10 -1% by mass.
本発明の水性頭皮外用剤には、さらに、成分(H)グリチルレチン酸、グリチルリチン酸、グリチルリチン酸ジカリウム、グリチルレチン酸ステアリルを健康な頭皮への改善効果の面から少なくとも1種または2種以上含有することができる。全組成中の含有量は、健康な頭皮への改善効果の面から1×10−4〜5質量%が好ましく、なかでも5×10−3〜1質量%、特に1×10−2〜5×10−1質量%が好ましい。 The aqueous scalp external preparation of the present invention further contains at least one or two or more components (H) glycyrrhetinic acid, glycyrrhizic acid, dipotassium glycyrrhizinate, and stearyl glycyrrhetinate from the aspect of improving the healthy scalp. Can do. The content in the total composition is preferably 1 × 10 −4 to 5% by mass, particularly 5 × 10 −3 to 1% by mass, particularly 1 × 10 −2 to 5%, from the viewpoint of the effect of improving healthy scalp. × 10 −1 mass% is preferable.
本発明の水性頭皮外用剤には、必要に応じて、更に、抗菌剤、毛包賦活剤、保湿剤、角質溶解剤、抗脂漏剤、局所刺激剤、抗男性ホルモン剤、カリウムチャンネルオープナー及び抗酸化剤から選ばれる成分を1種又は2種以上を組み合わせて配合することができる。これらの成分は、本発明の水性頭皮外用剤中に、1×10−3〜3×10質量%、好ましくは1×10−2〜1.5×10質量%で含有するのが好ましい。 The aqueous scalp external preparation of the present invention further contains an antibacterial agent, hair follicle activator, moisturizer, keratolytic agent, antiseborrheic agent, local stimulant, antiandrogen, potassium channel opener and One or more components selected from antioxidants can be blended. These components are contained in the aqueous scalp external preparation of the present invention in an amount of 1 × 10 −3 to 3 × 10 mass%, preferably 1 × 10 −2 to 1.5 × 10 mass%.
抗菌剤としては、例えばイソプロピルメチルフェノール、塩化ベンザルコニウム、オクトピロックス、感光色素101、感光色素201、クロルヘキシジン、サリチル酸、ジンクピリチオン、ソルビン酸カリウム、ヒノキチオール、フェノール等が挙げられる。これらのうち、特にイソプロピルメチルフェノール、塩化ベンザルコニウム、オクトピロックス、ジンクピリチオン、ヒノキチオール等が好ましく挙げられる。 Examples of the antibacterial agent include isopropylmethylphenol, benzalkonium chloride, octopirox, photosensitive dye 101, photosensitive dye 201, chlorhexidine, salicylic acid, zinc pyrithione, potassium sorbate, hinokitiol, phenol and the like. Of these, isopropylmethylphenol, benzalkonium chloride, octopirox, zinc pyrithione, hinokitiol and the like are particularly preferable.
毛包賦活剤としては、例えばトランス−3,4′−ジメチル−3−ヒドロキシフラバノン、アデノシン、パントテニルエチルエーテル、サイトプリン、N−アセチル−L−メチオニン、タマサキツヅラフジ、セファランチン、アデノシン三リン酸ジナトリウム、アスパラギン酸カリウム、感光色素301、ペンタデカン酸グリセリド、パントテン酸エチル、チクセツニンジン、ビオチン、モノニトログアヤコールナトリウム、酵母エキス、ニンニク成分、真珠蛋白抽出液、タイソウエキス、プラセンタエキス、ローヤルゼリー、ソフォラ抽出ペースト(クジン)、6−ベンジルアミノプリン、ジアルキルモノアミン誘導体等が挙げられる。これらのうち、特にタマサキツヅラフジ、セファランチン、アデノシン三リン酸ジナトリウム、ペンタデカングリセリド、パントテン酸エチル、チクセツニンジン、ビオチン、モノニトログアヤコールナトリウム、プラセンタエキス、ローヤルゼリー等が挙げられる。 Examples of hair follicle activators include trans-3,4'-dimethyl-3-hydroxyflavanone, adenosine, pantothenyl ethyl ether, cytopurine, N-acetyl-L-methionine, Tamazaki kurafuji, cephalanthin, adenosine triphosphate Disodium, potassium aspartate, photosensitive dye 301, pentadecanoic acid glyceride, ethyl pantothenate, chixet carrot, biotin, mononitroguaiacol sodium, yeast extract, garlic component, pearl protein extract, tiso extract, placenta extract, royal jelly, sophora Examples include extraction paste (kudin), 6-benzylaminopurine, dialkyl monoamine derivatives, and the like. Among these, particularly Japanese cypress rafji, cephalanthin, adenosine triphosphate disodium, pentadecane glyceride, ethyl pantothenate, chixetsuninjin, biotin, sodium mononitroguaiacol, placenta extract, royal jelly and the like.
保湿剤としては、例えばオトギリソウエキス、カラスムギエキス、可溶性コラーゲン、グリセリン、コンドロイチン硫酸、チューベロースポリサッカライド、プロピレングリコール、冬虫夏草エキス、延命草エキス、オオムギエキス、オレンジエキス、ブドウエキス、海藻エキス、ボタンピエキス、ジオウエキス、デュークエキス、マイカイ花エキス、ヨクイニンエキス、パナックスジンセンエキス、デルアミド、アルテア抽出液、クアチャララーテ抽出液、ヒレハリソウ抽出物、コリアンダー抽出液、サンショウ抽出物、アマチャ抽出液、ホップエキス等が挙げられる。これらのうち、特にオトギリソウエキス、カラスムギエキス、グリセリン、チューベロースポリサッカライド、冬虫夏草エキス、延命草エキス、オオムギエキス、ブドウエキス、海藻エキス、ポタンピエキス、ジオウエキス、デュークエキス、マイカイ花エキス、ヨクイニンエキス等が挙げられる。 Examples of the moisturizing agent include hypericum extract, oat extract, soluble collagen, glycerin, chondroitin sulfate, tuberose polysaccharide, propylene glycol, cordyceps extract, life-grass extract, barley extract, orange extract, grape extract, seaweed extract, button pi extract , Jiou extract, Duke extract, Maikai flower extract, Yokuinin extract, Panax ginseng extract, Delamide, Altea extract, Kuchachararate extract, Japanese spinach extract, Coriander extract, Salamander extract, Achacha extract, Hop extract, etc. It is done. Among these, especially Hypericum extract, Oat extract, Glycerin, Tuberose polysaccharide, Cordyceps extract, Life-extending grass extract, Barley extract, Grape extract, Seaweed extract, Potampi extract, Diou extract, Duke extract, Maikai flower extract, Yakuinin extract, etc. Can be mentioned.
角質溶解剤としては、例えばアスピリン等が挙げられる。抗脂漏剤としては、例えばイオウ、レシチン、カシュウエキス、チオキソロン等が挙げられる。 Examples of the keratolytic agent include aspirin. Examples of antiseborrheic agents include sulfur, lecithin, cachet extract, and thioxolone.
局所刺激剤としては、例えばカンファー、トウガラシチンキ、l−メントール、ノニル酸ワニリルアミド、ショウキョウチンキ、オランダガラシ、カンタリスチンキ、サンショウエキス、ハッカ油、ワサビ大根エキス等が挙げられる。抗男性ホルモン剤としては、例えばサイプロテロンアセテート、11α−ハイドロキシプロゲステロン、フルタマイド、3−デオキシアデノシン、酢酸クロルマジノン、エチニルエストラジオール、スピロノラクトン、エピテステロン、アロエ、サンショウ、オタネニンジン等が挙げられる。 Examples of the local stimulant include camphor, capsicum tincture, l-menthol, nonyl acid vanillylamide, ginger tincture, Dutch pepper, cantalis tincture, salamander extract, peppermint oil, horseradish radish extract and the like. Examples of anti-androgenic agents include cyproterone acetate, 11α-hydroxyprogesterone, flutamide, 3-deoxyadenosine, chlormadinone acetate, ethinyl estradiol, spironolactone, epitesterone, aloe, salamander, ginseng and the like.
カリウムチャンネルオープナーとしては、例えばミノキシジル、クロマカリウム、ジアゾキシド及びその誘導体、ピナシジル等が挙げられる。 Examples of the potassium channel opener include minoxidil, chroma potassium, diazoxide and derivatives thereof, pinacidil and the like.
抗酸化剤としては、例えば紅茶エキス、茶エキス、チョウジエキス、エイジツエキス、黄杞エキス、ビタミンC及びその誘導体、エリソルビン酸、没食子酸プロピル、ジブチルヒドロキシトルエン等が挙げられる。 Examples of the antioxidant include black tea extract, tea extract, clove extract, age extract, jaundice extract, vitamin C and its derivatives, erythorbic acid, propyl gallate, dibutylhydroxytoluene and the like.
本発明の水性頭皮外用剤には、更に、非イオン性界面活性剤、陽イオン性界面活性剤、陰イオン性界面活性剤及び両性界面活性剤から選ばれる一種以上の界面活性剤を配合することができる。かかる界面活性剤としては、通常の化粧料等に用いられるものであれば特に制限されず、例えば非イオン性界面活性剤としては、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリルエーテル、ポリオキシエチレン誘導体、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビトール脂肪酸エステル等が挙げられ、陽イオン性界面活性剤としては、第3級アミン塩、第4級アンモニウム塩等が挙げられ、陰イオン性界面活性剤としては、ラウリル硫酸塩、ポリオキシエチレンラウリルエーテル硫酸塩等が挙げられ、そして両性界面活性剤としては、アルキルベタイン、アミンオキサイド等が挙げられる。これらの成分は、全組成中には5×10−3〜2×10質量%、より好ましくは1×10−2〜1×10質量%である。 The aqueous scalp external preparation of the present invention further contains one or more surfactants selected from nonionic surfactants, cationic surfactants, anionic surfactants and amphoteric surfactants. Can do. Such a surfactant is not particularly limited as long as it is used in ordinary cosmetics and the like. For example, nonionic surfactants include polyoxyethylene alkyl ether, polyoxyethylene alkyl allyl ether, polyoxyethylene. Derivatives, polyoxyethylene fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene sorbitol fatty acid esters, and the like. Examples of cationic surfactants include tertiary amine salts, And the like. Examples of the anionic surfactant include lauryl sulfate and polyoxyethylene lauryl ether sulfate. Examples of the amphoteric surfactant include alkyl betaine and amine oxide. . These components are 5 * 10 < -3 > -2 * 10 mass% in the whole composition, More preferably, they are 1 * 10 <-2 > -1 * 10 mass%.
本発明の水性頭皮外用剤は、通常の方法に従って製造することができ、例えば、前述の成分(A)〜(F)及び他の成分を、常法に従って均一に混合することにより製造することができる。また、前述の成分(D)、成分(E)、成分(G)を混合溶解し、さらに成分(A)、(B)、(C)、(F)、(H)及び他の成分を加え、混合溶解し、製造することができる。 The aqueous scalp external preparation of the present invention can be produced according to a usual method, for example, it can be produced by uniformly mixing the aforementioned components (A) to (F) and other components according to a conventional method. it can. Also, component (D), component (E), and component (G) are mixed and dissolved, and components (A), (B), (C), (F), (H) and other components are added. , Mixed and dissolved.
本発明の水性頭皮外用剤は、配合する他の添加剤や剤型に応じて、化粧品、医薬品、医薬部外品等として使用することができる。ここで、剤型としては、頭皮に本発明の水性頭皮外用剤を適用できる剤型であれば特に制限されず、例えばローション、トニック、クリーム、ジェル、フォーム、スプレー、エアゾールなどの剤形とすることができる。また、噴射剤を含有したエアゾール剤とする場合、噴射剤としては、例えば炭酸ガス、LPG、ジメチルエーテル、窒素ガス、イソペンタン、亜酸化窒素等が挙げられ、これらは1種又は2種以上を組み合わせて用いることができる。噴射剤としては、使用感の点から、特に炭酸ガスが好ましい。 The aqueous scalp external preparation of the present invention can be used as cosmetics, pharmaceuticals, quasi drugs, etc., depending on other additives and dosage forms to be blended. Here, the dosage form is not particularly limited as long as the aqueous scalp external preparation of the present invention can be applied to the scalp, and for example, a dosage form such as lotion, tonic, cream, gel, foam, spray, aerosol, etc. be able to. Moreover, when setting it as the aerosol agent containing a propellant, as a propellant, carbon dioxide gas, LPG, dimethyl ether, nitrogen gas, isopentane, nitrous oxide etc. are mentioned, for example, These are 1 type or in combination of 2 or more types. Can be used. As the propellant, carbon dioxide gas is particularly preferable from the viewpoint of usability.
本発明の水性頭皮外用剤の使用方法としては、頭皮に水性頭皮外用剤が付着するような態様であれば特に制限されることはない。 The method for using the aqueous scalp external preparation of the present invention is not particularly limited as long as the aqueous scalp external preparation adheres to the scalp.
以下、実施例を挙げ、本発明を更に具体的に説明するが、本発明はこれら実施例に限定されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated further more concretely, this invention is not limited to these Examples.
表−1で使用した成分(C)としてのN−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体C1、C2は以下の方法で製造した。
(C1の製造方法)
硫酸ジエチル0.8g(0.005モル)と2−エチル−2−オキサゾリン12.8g(0.14モル)、脱水した酢酸エチル29gから、数平均分子量2700のポリ(N−プロピオニルエチレンイミン)を得た。更に、側鎖一級アミノプロピル変性ポリジメチルシロキサン(重量平均分子量100000、アミン当量20000)100gを用いて、N−プロピオニルエチレンイミン−ジメチルシロキサン共重合体を淡黄色ゴム状固体(111g、収率98%)として得た。最終生成物のオルガノポリシロキサンセグメントの含有率は88質量%であり、重量平均分子量は114000であった。溶媒としてメタノールを使用した塩酸による中和滴定の結果、アミノ基は残存していないことがわかった。
N-propionylpolyethyleneimine / methylpolysiloxane copolymers C1 and C2 as the component (C) used in Table 1 were produced by the following method.
(Method for producing C1)
Poly (N-propionylethyleneimine) having a number average molecular weight of 2700 was obtained from 0.8 g (0.005 mol) of diethyl sulfate, 12.8 g (0.14 mol) of 2-ethyl-2-oxazoline and 29 g of dehydrated ethyl acetate. Obtained. Further, 100 g of side chain primary aminopropyl-modified polydimethylsiloxane (weight average molecular weight 100000, amine equivalent 20000) was used to convert N-propionylethyleneimine-dimethylsiloxane copolymer into a pale yellow rubber-like solid (111 g, yield 98%). ). The content of the organopolysiloxane segment in the final product was 88% by mass, and the weight average molecular weight was 114,000. As a result of neutralization titration with hydrochloric acid using methanol as a solvent, it was found that no amino group remained.
(C2の製造方法)
C1と同様の方法により、硫酸ジエチル6.5g(0.042モル)と2−エチル−2−オキサゾリン34.4g(0.36モル)、脱水した酢酸エチル87gから、数平均分子量1300のポリ(N−プロピオニルエチレンイミン)を得た。更に、側鎖一級アミノプロピル変性ポリジメチルシロキサン(重量平均分子量32000、アミン当量2000)100gを用いて、N−プロピオニルエチレンイミン−ジメチルシロキサン共重合体を淡黄色ゴム状半固体(138g、収率98%)として得た。最終生成物のオルガノポリシロキサンセグメントの含有率は71質量%、重量平均分子量は46000であった。溶媒としてメタノールを使用した塩酸による中和滴定の結果、約22質量%のアミノ基が残存していることがわかった。
(Method for producing C2)
In the same manner as C1, 6.5 g (0.042 mol) of diethyl sulfate, 34.4 g (0.36 mol) of 2-ethyl-2-oxazoline, and 87 g of dehydrated ethyl acetate were used to obtain a poly ( N-propionylethyleneimine) was obtained. Further, 100 g of side chain primary aminopropyl-modified polydimethylsiloxane (weight average molecular weight 32000, amine equivalent 2000) was used to convert N-propionylethyleneimine-dimethylsiloxane copolymer into a pale yellow rubber-like semisolid (138 g, yield 98). %). The final product had an organopolysiloxane segment content of 71% by mass and a weight average molecular weight of 46,000. As a result of neutralization titration with hydrochloric acid using methanol as a solvent, it was found that about 22% by mass of amino groups remained.
本実施例において使用するN−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体C1、C2の物性を表1に示す。 Table 1 shows the physical properties of the N-propionyl polyethyleneimine / methyl polysiloxane copolymers C1 and C2 used in this example.
MWsi/MWt:N−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体の全重量中のオルガノポリシロキサンセグメント(MWsi)の含有率
MWsi:主鎖を構成するオルガノポリシロキサンセグメントの重量平均分子量
MWox:ポリ(N−プロピオニルポリエチレンイミン)セグメントの数平均分子量
MWt :N−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体の重量平均分子量
MWsi / MWt: Content of organopolysiloxane segment (MWsi) in the total weight of N-propionylpolyethyleneimine / methylpolysiloxane copolymer MWsi: Weight average molecular weight of organopolysiloxane segment constituting main chain MWox: Poly ( N-propionylpolyethyleneimine) segment number average molecular weight MWt: N-propionylpolyethyleneimine / methylpolysiloxane copolymer weight average molecular weight
表−1で使用した成分(D1)は以下の方法で製造した。
(D1の製造方法)
The component (D1) used in Table 1 was produced by the following method.
(Method for producing D1)
<カチオン性基含有共重合体の製造例1>
1Lビーカーにイオン交換水267.4g、MOEDES(ジメチルアミノエチルメタクリレートとジメチル硫酸の当モル付加物(有効分80重量%)。いずれも試薬、和光純薬工業(株)製)185.63g(有効分148.50g)、DMAAm(N,N−ジメチルアクリルアミド、試薬、和光純薬工業(株)製)110.46g、NK−14G(架橋剤、ポリエチレングリコールジメタクリレート、新中村化学(株)製)0.415g、V−50(重合開始剤、2,2&apos;−アゾビス(2−アミジノプロパン)・2塩酸塩、和光純薬工業(株)製)0.952gを混合し、モノマー水溶液Aとした。5Lのガラス容器にシクロヘキサン1648g、分散剤としてシュガーエステルS−770(三菱化成(株)製)を1.94g仕込み、60℃で1時間かけ均一に溶解せしめた。溶解後、30℃に冷却し、分散剤溶液Bとした。
<Production Example 1 of cationic group-containing copolymer>
In a 1 L beaker, 267.4 g of ion-exchanged water, MOEDES (Equimolar adduct of dimethylaminoethyl methacrylate and dimethylsulfate (effective content 80% by weight), both reagents, Wako Pure Chemical Industries, Ltd.) 185.63 g (effective 148.50 g), DMAAm (N, N-dimethylacrylamide, reagent, manufactured by Wako Pure Chemical Industries, Ltd.) 110.46 g, NK-14G (crosslinking agent, polyethylene glycol dimethacrylate, manufactured by Shin-Nakamura Chemical Co., Ltd.) 0.415 g, V-50 (polymerization initiator, 2,2 ' -azobis (2-amidinopropane) .dihydrochloride, manufactured by Wako Pure Chemical Industries, Ltd.) 0.952 g were mixed to obtain an aqueous monomer solution A. . Into a 5 L glass container, 1648 g of cyclohexane and 1.94 g of sugar ester S-770 (manufactured by Mitsubishi Kasei Co., Ltd.) as a dispersant were charged and dissolved uniformly at 60 ° C. over 1 hour. After dissolution, the mixture was cooled to 30 ° C. to obtain Dispersant Solution B.
分散剤溶液Bに、前記モノマー水溶液Aを加え、ホモミキサー(ROBOMICS、特殊機化工業(株)製)にセットし、9000回転で4分間攪拌し、平均粒子径5μmのモノマー分散液を得た。全量を5Lの攪拌機と温度計、冷却管の付いたSUS槽に仕込み、窒素置換後、昇温し、55℃で1時間重合した。さらに70℃で1時間熟成した後、冷却管付きの脱水管を装着し、約2時間かけて系内から水269gを除去した。脱水が進むにつれ、槽内温度は70℃から90℃に上昇した。 The monomer aqueous solution A is added to the dispersant solution B, set in a homomixer (ROBOMICS, manufactured by Tokki Kika Kogyo Co., Ltd.), and stirred at 9000 rpm for 4 minutes to obtain a monomer dispersion having an average particle size of 5 μm. . The whole amount was charged into a 5 L SUS tank equipped with a stirrer, a thermometer and a cooling tube, purged with nitrogen, heated, and polymerized at 55 ° C for 1 hour. Further, after aging at 70 ° C. for 1 hour, a dehydrating tube with a cooling tube was attached, and 269 g of water was removed from the system over about 2 hours. As dehydration progressed, the temperature in the tank increased from 70 ° C to 90 ° C.
ついで40℃以下に冷却し、内容物をステンレス製トレーに移し、80℃、熱風乾燥して溶媒を除去し、白色・粒状のカチオン性基含有共重合体1を得た。なお、実施例で用いたカチオン性基含有共重合体1は、家庭用コーヒーミルで約1秒間、軽く粉砕し平均粒子径4.0μmのカチオン性基含有共重合体D1を得た。 Subsequently, it was cooled to 40 ° C. or lower, and the contents were transferred to a stainless steel tray and dried with hot air at 80 ° C. to remove the solvent, thereby obtaining a white / granular cationic group-containing copolymer 1. The cationic group-containing copolymer 1 used in the examples was lightly pulverized in a household coffee mill for about 1 second to obtain a cationic group-containing copolymer D1 having an average particle size of 4.0 μm.
表2においてセンブリエキス、ユーカリエキスは、市販されている溶液状態での含有量に基づいて示されている。センブリエキスの乾燥質量の場合、市販品、例えば、(一丸ファルコス)原料名:スエルチアニンでは、乾燥質量:0.9〜1.1質量%である。また、ユーカリエキスの乾燥質量の場合、市販品、例えば(丸善製薬)原料名:ユーカリ抽出液BG−KAでは、乾燥残分:0.15〜0.25質量%である。
ここで、乾燥質量は、エキス10mlを105℃で6時間加熱し、乾燥した後の質量の当該10mlのエキスに対する比率(質量%)として得られる。
In Table 2, the assembly extract and eucalyptus extract are shown based on the content in a commercially available solution state. In the case of the dry weight of the assembly extract, in the case of a commercially available product, for example, (Ichimaru Falcos) raw material name: Srutianin, the dry weight is 0.9 to 1.1% by mass. Moreover, in the case of the dry mass of a eucalyptus extract, in a commercial item, for example (Maruzen Pharmaceutical Co., Ltd.) raw material name: Eucalyptus extract BG-KA, it is a dry residue: 0.15-0.25 mass%.
Here, the dry mass is obtained as a ratio (mass%) of 10 ml of the extract at 105 ° C. for 6 hours and dried to the 10 ml of the extract.
(実施例1〜8及び比較例1〜3)
表2に示す組成の成分(D)、成分(E)、成分(G)を混合溶解し、さらに成分(A)、(B)、(C)、(F)、(H)及び他の成分を加え、混合溶解することにより、水性頭皮外用剤を調整した。なお、表2中、成分の含有量の単位は質量%である。実施例1と比較例1,2,3、実施例3と比較例1,2,3より、(C)成分、(D)成分が組み合わさることで、髪のハリコシ、しなやかさ、ボリューム感が顕著になることがわかる。
(Examples 1-8 and Comparative Examples 1-3)
The components (D), (E), and (G) having the composition shown in Table 2 are mixed and dissolved, and the components (A), (B), (C), (F), (H) and other components are mixed. Was added and mixed and dissolved to prepare an aqueous scalp external preparation. In Table 2, the unit of component content is mass%. From Example 1 and Comparative Examples 1, 2, 3, and Example 3 and Comparative Examples 1, 2, 3, the combination of the component (C) and the component (D) gives the hair firmness, suppleness, and volume. It turns out that it becomes remarkable.
得られた各水性頭皮外用剤1gを、被験者10名に対し、1日に2回、約10cm四方の頭皮部分に塗布し、開始時と比較した。評価項目は、塗布直後のべたつきのなさ、直後の髪のハリコシ、直後の髪の軽い滑らかさ、直後の髪のしなやかさ、直後の髪のボリューム感、塗布後2週間の髪のボリューム感について、2名の熟練した評価者が目視及び触診で以下の1〜5点の5段階で評価した。得られた結果を表2に示す。
9名以上効果ありと判定 :5
7、8名以上効果ありと判定:4
5、6名効果ありと判定 :3
3、4名効果ありと判定 :2
2名以下が効果ありと判定 :1
Each aqueous scalp preparation 1 g thus obtained was applied to a scalp portion about 10 cm square twice a day for 10 subjects and compared with the start time. Evaluation items are: no stickiness immediately after application, sharpness of hair immediately after application, light smoothness of hair immediately after application, suppleness of hair immediately after application, volume of hair immediately after application, and volume of hair for 2 weeks after application. Two skilled evaluators evaluated the following 1 to 5 points by visual inspection and palpation. The obtained results are shown in Table 2.
Determined to be effective by 9 or more people: 5
7, 8 or more people judged to be effective: 4
5 or 6 people judged to have effect: 3
3 and 4 people are judged to be effective: 2
2 or less people judged to be effective: 1
(実施例9)
表3に示す組成の成分(D)、成分(E)、成分(G)を混合溶解し、さらに成分(A)、(B)、(C)、(F)、(H)及び他の成分を加え、混合溶解することにより、ローション原液を得る。このローションを97.5g、二酸化炭素を2.5g、それぞれエアゾール容器に充填し、エアゾールタイプの育毛剤を調整した。なお、表3中、成分の含有量の単位は質量%である。
Example 9
Components (D), (E), and (G) having the composition shown in Table 3 are mixed and dissolved, and components (A), (B), (C), (F), (H), and other components are mixed. To obtain a lotion stock solution. 97.5 g of this lotion and 2.5 g of carbon dioxide were each filled into an aerosol container to prepare an aerosol type hair restorer. In Table 3, the unit of content of components is mass%.
Claims (5)
(A)センブリエキス、ビタミンE類、およびニコチン酸類から選ばれる少なくとも1種の血行促進成分;
(B)ユーカリエキス;
(C)1×10−1〜1×10質量%のN−プロピオニルポリエチレンイミン・メチルポリシロキサン共重合体;
(D)5×10−2〜5質量%のN,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体;
(E)2×10〜6×10質量%のエタノール;
及び(F)水を含有する水性頭皮外用剤。 The following components (A) to (F):
(A) at least one blood circulation promoting component selected from assembly extract, vitamin E, and nicotinic acid;
(B) Eucalyptus extract;
(C) 1 × 10 −1 to 1 × 10 mass% of N-propionylpolyethyleneimine / methylpolysiloxane copolymer;
(D) 5 × 10 −2 to 5% by mass of N, N-dimethylaminoethyl diethyl methacrylate methacrylate / N, N-dimethylacrylamide / polyethylene glycol dimethacrylate copolymer;
(E) 2 × 10-6 × 10 mass% ethanol;
And (F) an aqueous scalp preparation containing water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009160454A JP4887407B2 (en) | 2009-07-07 | 2009-07-07 | Aqueous scalp external preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009160454A JP4887407B2 (en) | 2009-07-07 | 2009-07-07 | Aqueous scalp external preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011016729A true JP2011016729A (en) | 2011-01-27 |
JP4887407B2 JP4887407B2 (en) | 2012-02-29 |
Family
ID=43594818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009160454A Active JP4887407B2 (en) | 2009-07-07 | 2009-07-07 | Aqueous scalp external preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4887407B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013237639A (en) * | 2012-05-15 | 2013-11-28 | Cosmo Beauty:Kk | Hair cosmetic |
JP2014058489A (en) * | 2012-09-19 | 2014-04-03 | Kao Corp | Hair growth inhibitor |
WO2014112219A1 (en) * | 2013-01-21 | 2014-07-24 | 富士フイルム株式会社 | External preparation for skin |
JP2015081255A (en) * | 2013-10-24 | 2015-04-27 | 株式会社ミルボン | Hair treatment agent |
JP2017122131A (en) * | 2017-04-17 | 2017-07-13 | 花王株式会社 | Hair growth inhibitor |
JP2017145206A (en) * | 2016-02-16 | 2017-08-24 | 花王株式会社 | Aerosol-type cosmetics for scalp |
-
2009
- 2009-07-07 JP JP2009160454A patent/JP4887407B2/en active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013237639A (en) * | 2012-05-15 | 2013-11-28 | Cosmo Beauty:Kk | Hair cosmetic |
JP2014058489A (en) * | 2012-09-19 | 2014-04-03 | Kao Corp | Hair growth inhibitor |
WO2014112219A1 (en) * | 2013-01-21 | 2014-07-24 | 富士フイルム株式会社 | External preparation for skin |
JP5931223B2 (en) * | 2013-01-21 | 2016-06-08 | 富士フイルム株式会社 | Skin preparation |
JP2015081255A (en) * | 2013-10-24 | 2015-04-27 | 株式会社ミルボン | Hair treatment agent |
JP2017145206A (en) * | 2016-02-16 | 2017-08-24 | 花王株式会社 | Aerosol-type cosmetics for scalp |
JP2017122131A (en) * | 2017-04-17 | 2017-07-13 | 花王株式会社 | Hair growth inhibitor |
Also Published As
Publication number | Publication date |
---|---|
JP4887407B2 (en) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4887407B2 (en) | Aqueous scalp external preparation | |
CN102065835B (en) | Cosmetic or pharmaceutical compositions comprising modified polysiloxanes with at least one carbamate group | |
CN1778287B (en) | Increased moisturization efficacy using hydroxyalkylurea | |
JP5502290B2 (en) | Hair cosmetics | |
KR20070083502A (en) | Hair care preparations | |
JP2010132569A (en) | Foam-shaped hair cosmetic | |
WO2010116940A1 (en) | Hair cosmetic | |
CN105640870A (en) | Skin care composition and skin care product with yeast extract | |
JP2014125477A (en) | Foam-shaped hair cosmetic | |
EP2436371A1 (en) | Hair cosmetic | |
WO2010116941A1 (en) | Hair cosmetic | |
CN101864027B (en) | Copolymers and their use in personal care compositions | |
JP6181445B2 (en) | Hair cosmetics | |
CN116615172A (en) | Composition comprising a natural polymer and one or more (bio) alkanediols | |
JP2012214508A (en) | Aqueous external preparation for scalp | |
EP3116468B1 (en) | Hair care sensory agents | |
JP2021515747A (en) | Topical composition | |
CN102325521A (en) | Cosmetic composition comprising cationic polymer and chitosan | |
CN103705402A (en) | Low oil cosmetic compositions comprising a 4-substituted resorcinol and a high carbon chain ester | |
JP2011098928A (en) | Hair cosmetic | |
JP7201411B2 (en) | Hair cleanser composition | |
JP5616607B2 (en) | Hair cosmetics | |
JP2014043426A (en) | Hair cosmetics | |
WO2012076531A2 (en) | Clear cosmetic compositions containing lipophilic materials | |
JP2016117673A (en) | Foamy cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111027 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111115 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111212 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141216 Year of fee payment: 3 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 4887407 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141216 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |